Curcumin nanogel and its efficacy against oxidative stress and inflammation in rat models of ischemic stroke

Papers of special note have been highlighted as: • of interest

References

• 1. Hicks A, Jolkkonen J. Challenges and possibilities of intravascular cell therapy in stroke. Acta. Neurobiol. Exp. (Wars.) 69(1), 1–11 (2009).
  MedlineGoogle Scholar
• 2. These J, Taghibiglou C. The overlooked aspect of excitotoxicity: glutamate-independent excitotoxicity in traumatic brain injuries. Eur. J. Neurosci. 49(9), 1157–1170 (2019).
  MedlineGoogle Scholar
• 3. Shah FA, Li T, Kury LTA et al. Pathological comparisons of the hippocampal changes in the transient and permanent middle cerebral artery occlusion rat models. Front. Neurol. 10, 1178 (2019).
  MedlineGoogle Scholar
• 4. Sultana R, Perluigi M, Butterfield DA. Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer's disease brain. Free Radic. Biol. Med. 62, 157–169 (2013).
  Medline CASGoogle Scholar
• 5. Ashafaq M, Alam MI, Khan A et al. Nanoparticles of resveratrol attenuates oxidative stress and inflammation after ischemic stroke in rats. Int. Immunopharmacol. 94, 107494 (2021). • Explores the effects of resveratrol nanoparticles on oxidative stress and inflammation in a rat model of ischemic stroke, suggesting significant therapeutic benefits in the management of poststroke complications.
  Medline CASGoogle Scholar
• 6. Kim YJ, Ko H, Park JS et al. Dimethyl cardamonin inhibits lipopolysaccharide-induced inflammatory factors through blocking NF-κB p65 activation. Int. Immunopharmacol. 10(9), 1127–1134 (2010).
  Medline CASGoogle Scholar
• 7. Maddahi A, Edvinsson L. Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway. J. Neuroinflamm. 7, 1–13 (2010).
  MedlineGoogle Scholar
• 8. Hewlings SJ, Kalman DS. Curcumin: a review of its effects on human health. Foods 6(10), 92 (2017).
  MedlineGoogle Scholar
• 9. Tanvir E, Hossen M, Hossain M et al. Antioxidant properties of popular turmeric (Curcuma longa) varieties from Bangladesh. J. Food Qual. 2017, 8471785 (2017).
  Google Scholar
• 10. Soleimani V, Sahebkar A, Hosseinzadeh H. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances. Phytother. Res. 32(6), 985–995 (2018).
  Medline CASGoogle Scholar
• 11. Tagde P, Tagde P, Islam F et al. The multifaceted role of curcumin in advanced nanocurcumin form in the treatment and management of chronic disorders. Molecules 26(23), 7109 (2021).
  Medline CASGoogle Scholar
• 12. Ishrat T, Hoda MN, Khan MB et al. Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT). Eur. Neuropsychopharmacol. 19(9), 636–647 (2009).
  Medline CASGoogle Scholar
• 13. Scazzocchio B, Minghetti L, D'Archivio M. Interaction between gut microbiota and curcumin: a new key of understanding for the health effects of curcumin. Nutrients 12(9), 2499 (2020).
  Medline CASGoogle Scholar
• 14. Sabet S, Rashidinejad A, Melton LD, McGillivray DJ. Recent advances to improve curcumin oral bioavailability. Trends Food Sci. Technol. 110, 253–266 (2021).
  CASGoogle Scholar
• 15. Patra JK, Das G, Fraceto LF et al. Nano based drug delivery systems: recent developments and future prospects. J. Nanobiotechnol. 16, 71 (2018).
  MedlineGoogle Scholar
• 16. Panzarini E, Mariano S, Tacconi S et al. Novel therapeutic delivery of nanocurcumin in central nervous system related disorders. Nanomaterials 11(1), 2 (2021).
  CASGoogle Scholar
• 17. Khuwaja G, Khan MM, Ishrat T et al. Neuroprotective effects of curcumin on 6-hydroxydopamine-induced Parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies. Brain Res. 1368, 254–263 (2011). • Showed that curcumin had neuroprotective effects in a rat model of Parkinson's disease caused by 6-hydroxydopamine, specifically examining its impact on behavior, neurochemistry and histology.
  Medline CASGoogle Scholar
• 18. Madkhali OA, Sivagurunathan Moni S, Sultan MH et al. Formulation and evaluation of injectable dextran sulfate sodium nanoparticles as a potent antibacterial agent. Sci. Rep. 11, 9914 (2021). • Highlights the critical role of hydrogen-bonding interactions between dextran sulfate sodium and tripolyphosphate in the formation of nanoparticles. The study demonstrated that nanoparticles crafted from dextran sulfate sodium exhibit significant potential as an innovative antibacterial treatment.
  Medline CASGoogle Scholar
• 19. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20, 84–91 (1989).
  Medline CASGoogle Scholar
• 20. Khan MM, Ahmad A, Ishrat T et al. Rutin protects the neural damage induced by transient focal ischemia in rats. Brain Res. 1292, 123–135 (2009).
  Medline CASGoogle Scholar
• 21. Kelly MA, Rubinstein M, Phillips TJ et al. Locomotor activity in D2 dopamine receptor deficient mice in determined by gene dosage, genetic background and developmental adaptations. J. Neurosci. 18, 7470–7479 (1998).
  Google Scholar
• 22. Utley HC, Bernheim F, Hochslein P. Effect of sulfhydryl reagent on peroxidation in microsome. Arch. Biochem. Biophys. 260, 521–531 (1967).
  Google Scholar
• 23. Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 11(3), 151–169 (1974).
  Medline CASGoogle Scholar
• 24. Carlberg I, Mannervik B. Glutathione reductase levels in rat brain. J. Biol. Chem. 250, 5475–5480 (1975).
  Medline CASGoogle Scholar
• 25. Mohandas J, Marshall JJ, Duggin GG, Horvath JS, Tiller D. Differential distribution of glutathione and glutathione related enzymes in rabbit kidneys, possible implication in analgesic neuropathy. Cancer Res. 44, 5086–5091 (1984).
  Medline CASGoogle Scholar
• 26. Stevens MJ, Obrosova I, Cao X, Van Huysen C, Greene DA. Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 49(6), 1006–1015 (2000).
  Medline CASGoogle Scholar
• 27. Claiborne A. Catalase activity. In: CRC Hand Book of Methods for Oxygen Radical Research. Green Wald RA (Ed.). CRC Press, FL, USA, 283–284 (1984).
  Google Scholar
• 28. Bhawana, Basniwal RK, Buttar HS, Jain VK, Jain N. Curcumin nanoparticles: preparation, characterization, and antimicrobial study. J. Agric. Food Chem. 59(5), 2056–2061 (2011).
  Medline CASGoogle Scholar
• 29. Pinheiro RGR, Coutinho AJ, Pinheiro M, Neves AR. Nanoparticles for targeted brain drug delivery: what do we know? Int. J. Mol. Sci. 22, 11654(2021).
  Medline CASGoogle Scholar
• 30. Singh SK, Dadhania P, Vuddanda PR, Jain A, Velaga S, Singh S. Intranasal delivery of asenapine loaded nanostructured lipid carriers: formulation, characterization, pharmacokinetic and behavioural assessment. RSC Adv. 6(3), 2032–2045 (2016).
  CASGoogle Scholar
• 31. Hanada S, Fujioka K, Inoue Y, Kanaya F, Manome Y, Yamamoto K. Cell-based in vitro blood–brain barrier model can rapidly evaluate nanoparticles' brain permeability in association with particle size and surface modification. Int. J. Mol. Sci. 15(2), 1812–1825 (2014).
  MedlineGoogle Scholar
• 32. Wohlfart S, Gelperina S, Kreuter J. Transport of drugs across the blood–brain barrier by nanoparticles. J. Control. Rel. 161(2), 264–273 (2012).
  Medline CASGoogle Scholar
• 33. Tang L, Yang X, Yin Q et al. Investigating the optimal size of anticancer nanomedicine. Proc. Natl Acad. Sci. USA 111(43), 15344–15349 (2014).
  Medline CASGoogle Scholar
• 34. Shen Y, Guo J, Chen G et al. Delivery of liposomes with different sizes to mice brain after sonication by focused ultrasound in the presence of microbubbles. Ultrasound Med. Biol. 42(7), 1499–1511 (2016).
  MedlineGoogle Scholar
• 35. Pathak L, Kanwal A, Agrawal Y. Curcumin loaded self-assembled lipid-biopolymer nanoparticles for functional food applications. J. Food Sci. Technol. 52(10), 6143–6156 (2015).
  Medline CASGoogle Scholar
• 36. Jiang R, Westwater ML, Noble S et al. Associations between grip strength, brain structure, and mental health in >40,000 participants from the UK Biobank. BMC Med. 20, 286 (2022).
  MedlineGoogle Scholar
• 37. da Silva Córneo E, de Bem Silveira G, Scussel R et al. Effects of gold nanoparticles administration through behavioral and oxidative parameters in animal model of Parkinson's disease. Biointerfaces 196, 111302 (2020).
  MedlineGoogle Scholar
• 38. Potphode ND, Daunde JA, Desai SS, Walvekar MV. Nano-curcumin: a potent enhancer of body antioxidant system in diabetic mice. Int. J. Phytomed. 10, 162–167 (2018).
  CASGoogle Scholar
• 39. Abdulmalek S, Eldala A, Awad D et al. Ameliorative effect of curcumin and zinc oxide nanoparticles on multiple mechanisms in obese rats with induced type 2 diabetes. Sci. Rep. 11, 20677 (2021).
  Medline CASGoogle Scholar
• 40. Ahmadi N, Hosseini MJ, Rostamizadeh K, Anoush M. Investigation of therapeutic effect of curcumin alpha and beta glucoside anomers against Alzheimer's disease by the nose to brain drug delivery. Brain Res. 1766, 147517 (2021).
  Medline CASGoogle Scholar
• 41. Abdulmalek S, Nasef M, Awad D, Balbaa M. Protective effect of natural antioxidant, curcumin nanoparticles, and zinc oxide nanoparticles against type 2 diabetes-promoted hippocampal neurotoxicity in rats. Pharmaceutics 13, 1937(2021).
  Medline CASGoogle Scholar
• 42. Singh A, Kukreti R, Saso L, Kukreti S. Oxidative stress: a key modulator in neurodegenerative diseases. Molecules 24, 1583 (2019).
  Medline CASGoogle Scholar
• 43. Pei J, Pan X, Wei G, Hua Y. Research progress of glutathione peroxidase family (GPx) in redoxidation. Front. Pharmacol. 14, 1147414 (2023).
  Medline CASGoogle Scholar
• 44. Shen LR, Xiao F, Yuan P et al. Curcumin-supplemented diets increase superoxide dismutase activity and mean lifespan in Drosophila. Age (Dordr.) 35(4), 1133–1142 (2013).
  Medline CASGoogle Scholar
• 45. Sahebkar A, Serban MC, Ursoniu S, Banach M. Effect of curcuminoids on oxidative stress: a systematic review and meta-analysis of randomized controlled trials. J. Funct. Foods 18, 898–909 (2015).
  CASGoogle Scholar
• 46. Chopra H, Dey PS, Das D et al. Curcumin nanoparticles as promising therapeutic agents for drug targets. Molecules 26, 4998 (2021).
  Medline CASGoogle Scholar
• 47. Mofidi Najjar F, Ghadari R, Yousefi R et al. Studies to reveal the nature of interactions between catalase and curcumin using computational methods and optical techniques. Int. J. Biol. Macromol. 95, 550–556 (2017).
  MedlineGoogle Scholar
• 48. Kakkar V, Muppu SK, Chopra K, Kaur IP. Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats. Eur. J. Pharm. Biopharm. 85(3 Pt A), 339–345 (2013).
  Medline CASGoogle Scholar
• 49. Moran PM, Higgins LS, Cordel B, Moser PC. Age related learning deficits in transgenic mice expressing the 721-amino acid isoform of human beta-amyloid precursor protein. Proc. Natl Acad. Sci. USA 92, 5341–5345 (1995).
  Medline CASGoogle Scholar